MARY MARTIN: Open Payments
NPI 1598286072 · JASPER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 30 payments from 11 companies in 2025. Trend: 2023 $1,338 · 2024 $678 · 2025 $760
Food & beverage: $675Education: $85
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $175 |
| Janssen Biotech, Inc. | 6 | $172 |
| Novo Nordisk Inc | 10 | $145 |
| AstraZeneca Pharmaceuticals LP | 3 | $76 |
| Antares Pharma, Inc. | 2 | $37 |
| Lundbeck LLC | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Teleflex LLC | 1 | $27 |
| Myriad Genetic Laboratories, Inc. | 1 | $24 |
| COLOPLAST CORP | 1 | $20 |
Products named: INTERSTIM, ERLEADA, FARXIGA, XYOSTED, REXULTI, BARRIGEL, PROLARIS, RYBREVANT.
Industry payments across AL — which companies pay providers there.
